303 related articles for article (PubMed ID: 21636306)
1. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.
Sheikpranbabu S; Haribalaganesh R; Gurunathan S
Diabetes Metab; 2011 Dec; 37(6):505-11. PubMed ID: 21636306
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B.
Yamagishi S; Nakamura K; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
Microvasc Res; 2005 May; 69(3):128-34. PubMed ID: 15896354
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes.
Chen BH; Jiang DY; Tang LS
Life Sci; 2006 Aug; 79(11):1040-8. PubMed ID: 16674981
[TBL] [Abstract][Full Text] [Related]
6. PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels.
Banumathi E; Sheikpranbabu S; Haribalaganesh R; Gurunathan S
Exp Eye Res; 2010 Jan; 90(1):89-96. PubMed ID: 19837064
[TBL] [Abstract][Full Text] [Related]
7. Pigment-epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3K/Akt activation in goat retinal pericytes.
Haribalaganesh R; Sheikpranbabu S; Elayappan B; Venkataraman D; Gurunathan S
Angiogenesis; 2009; 12(4):381-9. PubMed ID: 19904621
[TBL] [Abstract][Full Text] [Related]
8. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
[TBL] [Abstract][Full Text] [Related]
11. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress.
Kim J; Kim KM; Kim CS; Sohn E; Lee YM; Jo K; Kim JS
Free Radic Biol Med; 2012 Jul; 53(2):357-65. PubMed ID: 22609359
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M; Makita Z
Biochem Biophys Res Commun; 2002 Aug; 296(4):877-82. PubMed ID: 12200129
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells.
Sheikpranbabu S; Haribalaganesh R; Banumathi E; Sirishkumar N; Lee KJ; Gurunathan S
Life Sci; 2009 Nov; 85(21-22):719-31. PubMed ID: 19818798
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties.
Seki R; Yamagishi S; Matsui T; Yoshida T; Torimura T; Ueno T; Sata M; Okamura T
Biochem Biophys Res Commun; 2013 Feb; 431(4):693-7. PubMed ID: 23375814
[TBL] [Abstract][Full Text] [Related]
17. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.
Yamagishi S; Inagaki Y; Nakamura K; Abe R; Shimizu T; Yoshimura A; Imaizumi T
J Mol Cell Cardiol; 2004 Aug; 37(2):497-506. PubMed ID: 15276019
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.
Zhang SX; Wang JJ; Dashti A; Wilson K; Zou MH; Szweda L; Ma JX; Lyons TJ
J Mol Endocrinol; 2008 Sep; 41(3):135-43. PubMed ID: 18586837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
